Tesamorelin 10 mg

Tesamorelin 10 mg for research: identity and specifications

Tesamorelin (CAS 901758-09-6) is a synthetic analog of growth hormone-releasing hormone (GHRH), a 44-amino-acid chain with an N-terminal modification that confers greater stability than the endogenous molecule. Supplied in a 10 mg vial as a lyophilized powder, synthesized by SPPS and purified by HPLC to analytical grade.

Scientific context

In experimental models, GHRH analogs such as Tesamorelin are investigated for their interaction with pituitary GHRH receptors and the pulsatile release of growth hormone (GH) in cell culture and in animal models, including studies on the GH/IGF-1 axis.

• Interaction with GHRH receptors in in vitro assays
• Pulsatile GH release in experimental models

Technical specifications

Frequently asked questions

What is the purity of the Tesamorelin supplied?

≥98% by HPLC, with the lot-specific value in the certificate of analysis (COA).

How should the compound be stored?

At -20 °C, protected from light and moisture, until use.

Does the certificate of analysis accompany the lot?

Yes, it can be verified before purchase using the button on this page.

What is the difference between Tesamorelin and other GHRH analogs?

Its N-terminal modification distinguishes it structurally, as described in the peptide reference entry.

See: Peptide encyclopedia entry and How every lot is tested (HPLC, COA).

Research use only (RUO). This material is supplied for in vitro laboratory research only. It is not a drug, dietary supplement or cosmetic, and it is not intended for human or veterinary use, or for the diagnosis or treatment of any condition.